AffiliationAcademic Radiation Oncology, University of Manchester, Christie Hospital NHS Trust, Manchester M20 4BX, UK. firstname.lastname@example.org
MetadataShow full item record
AbstractThe expansion of our knowledge through the Human Genome Project has been accompanied by the development of new high-throughput techniques, which provide extensive capabilities for the analysis of a large number of genes or the whole genome. These assays can be carried out in various clinical samples at the DNA (genome), RNA (transcriptome) or protein (proteome) level. There is a belief that this genomic revolution, i.e. sequencing of the human genome and developments in high-throughput technology, heralds a future of personalised medicine. For clinical oncology, this progress should increase the possibility of predicting individual patient responses to radiotherapy. This review highlights some of the work involving sparsely ionising radiation and the new technologies.
CitationThe genomics revolution and radiotherapy. 2007, 19 (6):470-80 Clin Oncol
- [DNA arrays: technological aspects and applications].
- Authors: Bertucci F, Loriod B, Tagett R, Granjeaud S, Birnbaum D, Nguyen C, Houlgatte R
- Issue date: 2001 Mar
- Functional genomics, gene arrays, and the future of pathology.
- Authors: Gabrielson E, Berg K, Anbazhagan R
- Issue date: 2001 Dec
- DNA microarrays: from structural genomics to functional genomics. The applications of gene chips in dermatology and dermatopathology.
- Authors: Sellheyer K, Belbin TJ
- Issue date: 2004 Nov
- Application of expression genomics for predicting treatment response in cancer.
- Authors: Chin KV, Alabanza L, Fujii K, Kudoh K, Kita T, Kikuchi Y, Selvanayagam ZE, Wong YF, Lin Y, Shih WC
- Issue date: 2005 Nov
- Microarray-based DNA profiling to study genomic aberrations.
- Authors: Waddell N
- Issue date: 2008 Jul